Evidence map›Paper›PMID 31707507›Full record

SynthesisEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.

Quentin Le Bastard, Guillaume Chapelet, François Javaudin, Didier Lepelletier, Eric Batard, Emmanuel Montassier

Registry-linked trialAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07724522 (A Placebo Randomized Cross-Over Controlled Trial of Inulin Supplementation to Improve Cardiometabolic, Gut, and Vaginal Microbiome in Perimenopausal Women), which is not on this map. Cited by 131 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07724522 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Placebo Randomized Cross-Over Controlled Trial of Inulin Supplementation to Improve Cardiometabolic, Gut, and Vaginal Microbiome in Perimenopausal Women

TypeinterventionalSponsorGeorge Washington UniversityRan2026 to 2028Enrolled27ConditionsObesity & Overweight, Perimenopausal Women, Prebiotics, InulinArmsInulin, Maltodextrin (Placebo)
3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 3 syntheses or guidelines pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Quentin Le BastardMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France.
Guillaume ChapeletMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France.
François JavaudinMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France.
Didier LepelletierMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France.
Eric BatardMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France.
Emmanuel MontassierMicrobiotas Hosts Antibiotics and bacterial Resistances (MiHAR), Université de Nantes, 44000, Nantes, France. emmanuel.montassier@chu-nantes.fr.ORCID http://orcid.org/0000-0002-2313-1172
Centre Hospitalier Universitaire de Nantes · FRNantes Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInulin, consisting of repetitive fructosyl units linked by β(2,1) bonds, is a readily fermentable fiber by intestinal bacteria that generates large quantities of short-chain fatty acids (SCFA). In individuals with constipation, it was reported that inulin ingestion was associated with a significant increase in stool frequency, suggesting a potential impact of inulin on human gut microbiota composition. Progress in high-throughput technologies allow assessment of human-associated microbiomes in terms of diversity and taxonomic or functional composition, and can identify changes in response to a specific supplementation. Hence, to understand the effects of inulin on the human gut microbiome is pivotal to gain insight into their mechanisms of action.

methodsHere, we conducted a systematic review of human studies in adult individuals showing the effects of inulin on the gut microbiome. We searched in MEDLINE, EMBASE, Web of Science, and Scopus databases for articles in English published in peer-reviewed journals and indexed up until March 2019. We used multiple search terms capturing gut microbiome, gut microflora, intestinal microbiota, intestinal flora, gut microbiota, gut flora, microbial gut community, gut microbial composition, and inulin.

resultsOverall, nine original articles reported the effects of inulin on microbiome composition in adult humans, most of them being randomized, double-blind, placebo-controlled trials (n = 7). Studies varied significantly in design (3 studies associated inulin and oligofructose), supplementation protocols (from 5 to 20 gr per day of inulin consumed) and in microbiome assessment methods (16S sequencing, n = 7). The most consistent change was an increase in Bifidobacterium. Other concordant results included an increase in relative abundance of Anaerostipes, Faecalibacterium, and Lactobacillus, and a decrease in relative abundance of Bacteroides after inulin supplementation.

conclusionsOur systematic review assessed the evidence for the effects of inulin supplementation on the human gut microbiome. However, these in vivo studies did not confirm in vitro experiments as the taxonomic alterations were not associated with increase in short-chain fatty acids levels.

Indexed as

Clinical Studies as TopicDietary SupplementsGastrointestinal MicrobiomeHumansInulinMicrobiotaInulinDiversityGut microbiomeInulinPrebioticShort-chain fatty acids

Identifiers

PMID31707507
OpenAlexW2989432905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.